EnginZyme
Team size: 51 - 200
Sector: Manufacturing and materials
About EnginZyme
Founders: Karim Engelmark Cassimjee, Robin Chatterjee, Samuel Hargestam
Founded date: 2014
Connect: enginzyme.com
Company revenue: US$ 10 - 50 million
Investors: Bunge Ventures, Industrifonden, Navigare Ventures, SEB Venture Capital, Sofinnova Partners
Company stage: Series B
EnginZyme is a biotechnology company that specializes in biocatalysis. It creates products for easy and cost-efficient implementation of biocatalytic processes and helps the chemical industry transition to a sustainable way of operating. The company is driven by a mission to make biocatalysis the first choice for chemical process designers worldwide.